Ying Luo
Chief Executive Officer · GYRE THERAPEUTICS, INC.
- 2026
- Jun 10, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ying Luo files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Weiguo Ye - $870K in GYRE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ying Luo?
Ying Luo is a corporate insider, tracked as Chief Executive Officer of GYRE THERAPEUTICS, INC. (GYRE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Ying Luo last file a Form 4?
The most recent primary Form 4 on record is dated 10 June 2026, one of 2 filings going back to 2026.
Has Ying Luo been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($83K) across all tracked filings.
